PMID: 8610954May 1, 1996Paper

Disease management: new wine in new bottles?

Annals of Internal Medicine
J M Harris

Abstract

Cost pressures are driving the reorganization of the health care delivery system in the United States, causing health care delivery organizations to become larger and more diversified. These new health care delivery entities are arriving at the same time as a new approach to clinical care: commercial population-based medicine. This approach is sharing an increasing amount of space with the traditional physician-patient-based approach and offers strategies for managing a population's risk, demand, diseases, and outcomes. Although commercial population-based medicine strategies such as disease management may use many of the same tools as traditional public health approaches, they focus on the relatively short-term health needs of defined populations because of the underlying economic incentives facing payers. Population-based-medicine promises better use of resources and a systems approach to health care delivery, but it also presents the pitfalls of subversion by the needs of commercial companies, unanticipated adverse effects, and wide application without adequate preparation.

Associated Clinical Trials

Citations

Sep 15, 1998·Disease-a-month : DM·K Weiss
Jul 1, 1997·Urology·C L BennettM Ullman
Oct 25, 2003·Lancet·Jan M De MaeseneerChris van Weel
Feb 9, 1999·Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health·A S Bierman, C M Clancy
Feb 9, 1999·Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health·F GevirtzD B Nash
Apr 25, 2001·Journal of General Internal Medicine·A FernandezA B Bindman
May 31, 2001·Journal of the American Geriatrics Society·F W Porell, H B Miltiades
Nov 14, 1997·The New England Journal of Medicine·C J Homer
Apr 15, 1999·The New England Journal of Medicine·T Bodenheimer
Dec 15, 2005·Disease Management : DM·Jaan Sidorov, Claudia Schlosberg
Mar 10, 2001·Health Care Management Review·L R BurnsD Hilberman
Mar 12, 2005·Journal of Occupational and Environmental Medicine·Debra LernerSusan T Reisine
Feb 24, 2001·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·E H Morreim
Aug 18, 2001·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·E H Morreim
Aug 14, 1998·BMJ : British Medical Journal·T Richards
Jan 2, 2003·Medical Care Research and Review : MCRR·Kathryn E FlynnMargaret K Davis
Apr 11, 2008·Healthcare Management Forum·Christopher R GallantDenise A Sprague
Jul 1, 1997·Journal of the American Medical Informatics Association : JAMIA·R B ElsonD P Connelly
May 13, 1999·Clinical Therapeutics·E P Armstrong, D A Sclar
Apr 1, 1997·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·F L Reese, W R Smith
Mar 27, 1999·Cardiology Clinics·G C Friesinger, J Francis
Sep 26, 1997·Archives of Physical Medicine and Rehabilitation·M G StinemanS V Williams
Mar 26, 1998·Journal of the American Geriatrics Society·E H Morreim
Feb 15, 2001·The Journal of Allergy and Clinical Immunology·S D Sullivan, K B Weiss
Apr 25, 2003·American Journal of Medical Quality : the Official Journal of the American College of Medical Quality·Russell RothmanMichael Pignone
Dec 5, 1998·Journal of Evaluation in Clinical Practice·M J Mohler, J M Harris
Feb 6, 2020·Journal of Managed Care & Specialty Pharmacy·Laetitia A N'DriSeojin Park
Mar 20, 1998·Medizinische Klinik·N I Schmidlin-von Ziegler

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

JAMA : the Journal of the American Medical Association
T BodenheimerKevin Grumbach
BMJ : British Medical Journal
D J Hunter, G Fairfield
The New England Journal of Medicine
T Bodenheimer
BMJ : British Medical Journal
M Lawrence, T Williams
© 2021 Meta ULC. All rights reserved